The identification of BRCA1 nonsense variants in patients confers a high risk of breast and ovarian cancer onset as these variants lead to protein truncation and loss of function (Hayes et al., 2000; Richards et al., 2015; Fernandes et al., 2019). This evidence concerns the gene BRCA1 and ovarian cancer.